[F:1][C:2]1[CH:10]=[C:9]([I:11])[CH:8]=[CH:7][C:3]=1[C:4]([OH:6])=O.[CH3:12][C:13]1[C:14]([N:23]2[CH2:28][CH2:27][NH:26][CH2:25][CH2:24]2)=[N:15][CH:16]=[C:17]([C:19]([F:22])([F:21])[F:20])[CH:18]=1>>[F:1][C:2]1[CH:10]=[C:9]([I:11])[CH:8]=[CH:7][C:3]=1[C:4]([N:26]1[CH2:27][CH2:28][N:23]([C:14]2[C:13]([CH3:12])=[CH:18][C:17]([C:19]([F:22])([F:20])[F:21])=[CH:16][N:15]=2)[CH2:24][CH2:25]1)=[O:6]Using 2-fluoro-4-iodobenzoic acid (266 mg) and 1-(3-methyl-5-trifluoromethylpyridin-2-yl)piperazine (245 mg) described in Preparation Example 84 and by the reaction and treatment in the same manner as in Preparation Example 111, the title compound (507 mg) was obtained.